» Articles » PMID: 29667068

Characteristics and Survival Outcomes Associated with the Lack of Radiation in the Treatment of Glioblastoma

Overview
Journal Med Oncol
Publisher Springer
Specialty Oncology
Date 2018 Apr 19
PMID 29667068
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation increases survival in glioblastoma (GBM); however, 30% do not receive this treatment. We sought to identify characteristics associated with not receiving radiation and the impact on outcomes. We analyzed the Surveillance, Epidemiology, and End Results program (SEER) 18 registries 2000-2013 research database on 30,479 GBM cases that were aged 20 years and older. In total, 21,179 received radiation as first course of therapy, while 8218 did not with 5178 (63%) being 65 years and older. Early decisions on surgery often predicted radiation therapy with 61% having only a biopsy or no surgery at diagnosis. Radiation use as upfront therapy has slowly increased over time at a rate of 0.4% per year; still 25% did not receive radiation in 2013. Cases treated with radiation were more likely to be younger, underwent surgery, lived in a metropolitan area, had higher socioeconomic status, and were in a couple-based relationship. An increased survival in GBM was associated with the use of upfront radiation along with younger age, being of race other than white, undergoing surgery, and a more recent diagnosis. Not receiving radiation therapy adversely affects survival. A trend toward an increased use of radiation was observed although many young adults still do not receive this treatment. Decreased usage of radiation in the elderly and in biopsy-only surgeries was anticipated, but race, gender, and poverty were also statistically significant. Clinicians should be aware of this underutilization, and an increased usage of radiation should improve outcomes for glioblastoma.

Citing Articles

Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients.

Parker M, Kazemi F, Ahmed A, Kuo C, Nair S, Rincon-Torroella J J Neurooncol. 2024; 168(2):345-353.

PMID: 38662150 DOI: 10.1007/s11060-024-04677-4.


Area-level socioeconomic status is positively correlated with glioblastoma incidence and prognosis in the United States.

Gorenflo M, Shen A, Murphy E, Cullen J, Yu J Front Oncol. 2023; 13:1110473.

PMID: 37007113 PMC: 10064132. DOI: 10.3389/fonc.2023.1110473.

References
1.
Stupp R, Hegi M, Mason W, van den Bent M, Taphoorn M, Janzer R . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7. View

2.
Eifel P, Ho A, Khalid N, Erickson B, Owen J . Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. Int J Radiat Oncol Biol Phys. 2014; 89(2):249-56. DOI: 10.1016/j.ijrobp.2013.11.228. View

3.
Wong J, Xu B, Yeung H, Roeland E, Martinez M, Le Q . Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014; 90(1):224-30. PMC: 4187217. DOI: 10.1016/j.ijrobp.2014.03.050. View

4.
Ward E, Jemal A, Cokkinides V, Singh G, Cardinez C, Ghafoor A . Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54(2):78-93. DOI: 10.3322/canjclin.54.2.78. View

5.
Megwalu U, Sikora A . Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014; 140(9):855-60. DOI: 10.1001/jamaoto.2014.1671. View